Product Details
Place of Origin: hubei
Brand Name: desheng
Certification: ISO9000
Model Number: Blood collection tube additive
Payment & Shipping Terms
Minimum Order Quantity: 200KG
Price: Detailed discussion
Packaging Details: 500g /bottle
Delivery Time: 5 days
Payment Terms: L/C, T/T, D/P, Western Union
Supply Ability: 10t / month
Appearance: |
White Powder |
Packing: |
500g/bottle |
Model: |
Blood Collection Tube Additive |
Appearance: |
White Powder |
Packing: |
500g/bottle |
Model: |
Blood Collection Tube Additive |
Blood testing is an indispensable part of medical diagnosis. By collecting blood samples, doctors can obtain important information about the patient's health status. However, the use of blood coagulants is particularly crucial in the process of blood collection and testing. Blood coagulant is a chemical substance that accelerates blood coagulation, which can shorten the coagulation time of blood and facilitate subsequent detection and analysis. However, if blood coagulants are added excessively in blood collection vessels, it will have a series of adverse effects.
Product Name | Coagulant suspension | Efficient coagulation promoting powder |
Product appearance | It is a white suspended liquid | Off white powder |
Product performance | Has a faint organic solvent odor | Easy to absorb moisture (dry powder) |
Main components | Composed of thrombin, silica powder, emulsifier, surfactant, etc | Polymer, coagulation factors, etc |
Product function | Promote rapid blood coagulation | |
Manufacturer | Hubei Xindesheng Material Technology Co., Ltd |
The function and principle of blood coagulants
Blood coagulants simulate the coagulation process in the human body, accelerating the conversion of fibrinogen into fibrin in the blood, thereby forming a fibrin network that envelops blood cells and forms blood clots. This process not only helps to prevent blood from continuing to flow in the blood collection vessel, but also facilitates subsequent centrifugation operations to separate serum or plasma from blood cells.
Coagulant suspension
The direct impact of excessive addition of blood coagulants
1. Abnormal coagulation process. When excessive amounts of blood coagulants are added to blood collection vessels, it can lead to abnormal and rapid coagulation processes. Under normal circumstances, the function of blood coagulants is to simulate the coagulation process in the human body, but excessive addition can accelerate this process, causing blood to quickly coagulate in the collection tube. This not only increases the difficulty of collection, but may also affect subsequent blood sample processing and analysis.
2. Sample damage. The rapid coagulation process can cause the cells in the blood sample to rupture due to increased pressure, and the released intracellular substances can contaminate the sample, thereby affecting the accuracy of the detection results. In addition, rapidly coagulated blood may also form uneven clots, leading to incomplete separation of serum or plasma from blood cells, further affecting sample quality.
3. Detection error. Due to the rapid coagulation of blood, it may not be possible to fully centrifuge and separate serum or plasma, resulting in the use of a mixture containing blood cells for testing. This can lead to errors in the detection results, as the presence of blood cells may interfere with the normal operation of the detection instrument or cause non-specific reactions with the detection reagents. According to relevant research, excessive addition of blood coagulants may lead to an increase in the error rate of detection results.
Indirect effects of excessive addition of blood coagulants
1. Patient health risks. If there is an error in the diagnostic results due to excessive addition of blood coagulants, doctors may develop a diagnosis and treatment plan based on the incorrect results, thereby increasing the patient's health risk.
2. Waste of diagnostic and treatment resources. Incorrect diagnostic results may lead to patients receiving more diagnosis or examination, resulting in wastage of diagnostic and treatment resources. At the same time, in order to correct incorrect diagnostic results, more tests may be required, further increasing the burden on doctors in diagnosis.
3. The doctor-patient relationship is tense. Incorrect diagnostic results may lead to patient distrust of doctors and even trigger doctor-patient disputes. This not only affects the patient's diagnosis and treatment experience, but may also have a negative impact on the reputation of doctors and the image of hospitals.
Product packaging
Hubei Xindesheng Material Technology Co., Ltd. specializes in the production of coagulants and high-efficiency coagulant powders, and customers can choose according to their needs. In addition to coagulants and high-efficiency coagulant powders, Desheng also produces commonly used blood collection additives such as anticoagulants, serum separation gels, and silicides. After more than a decade of research and development and pursuit of quality, the series of blood collection additives has been sold to many regions both domestically and internationally, and is highly recognized by customers. If you are also interested, please click on the official website for inquiries!